Clinical Trials on C3G
Total 65 results
-
ChemoCentryxMedpace, Inc.CompletedC3 Glomerulopathy (C3G)United States, Spain, France, Netherlands, Belgium, Canada, Denmark, Germany, Ireland, Italy, United Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
Novartis PharmaceuticalsRecruitingC3GSpain, France, Switzerland, Germany, Greece, Turkey, Canada, India, United States, Czechia, Japan, Argentina, Brazil, Italy, Israel, United Kingdom, China, Belgium, Netherlands
-
Ohio State University Comprehensive Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); Food and Drug Administration...Recruiting
-
University of Massachusetts, WorcesterNational Institute on Drug Abuse (NIDA)Completed
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Sun Yat-sen UniversityRecruiting
-
Sun Yat-sen UniversityCompleted
-
Achieve Life SciencesCompletedVaping | E-Cig UseUnited States
-
Yale UniversityCompleted
-
University of PittsburghUniversity of Pittsburgh Medical CenterTerminatedAdolescent Behavior | E-Cig UseUnited States
-
Virginia Commonwealth UniversityRecruiting
-
Yale UniversityAmerican Heart AssociationRecruiting
-
University of VirginiaDuke UniversityRecruiting
-
Novartis PharmaceuticalsAvailableParoxysmal Nocturnal Hemoglobinuria (PNH) | C3 Glomerulopathy (C3G)
-
University Hospital, GrenobleClinical Investigation Centre for Innovative Technology Network; University... and other collaboratorsCompletedECG-PCG-CTG Acquisition on Pregnant Voluntary SubjectsFrance
-
University of PennsylvaniaNational Cancer Institute (NCI)Not yet recruitingSmoking | Tobacco Use | Cigarette Smoking | E-Cig Use
-
University of PittsburghAmerican Heart AssociationActive, not recruitingTobacco Use | Adolescent Behavior | E-Cig UseUnited States
-
University of PittsburghActive, not recruitingTobacco Use | Adolescent Behavior | E-Cig UseUnited States
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | E-Cig UseUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA); Pennington Biomedical Research CenterCompletedFood Intake | Energy Intake | Appetite | E-Cig UseUnited States
-
Ohio State University Comprehensive Cancer CenterRecruiting
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
University Hospital Inselspital, BerneCSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...UnknownTo Introduce Artificial Intelligence (AI) and Machine Learning in Cardiotocography (CTG) Interpretation to Improve Clinical UseSwitzerland
-
Eva Morava-KoziczNot yet recruitingPGM1-CDG - Phosphoglucomutase 1-Related Congenital Disorder of GlycosylationUnited States
-
Mayo ClinicChildren's Hospital of Philadelphia; Seattle Children's HospitalTerminated
-
Eva Morava-KoziczNot yet recruitingSLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationUnited States
-
Pennington Biomedical Research CenterCompletedAlcohol Drinking | Food Intake | Smoking Behaviors | Survey | Vaping | E-Cig UseUnited States
-
NovelMed TherapeuticsNot yet recruitingC3 Glomerulopathy
-
The First Affiliated Hospital with Nanjing Medical...CompletedOptical Coherence Tomography (OCT) | Percutaneous Coronary Intervention (PCI) | Single-Photon Emission Computed Tomography (SPECT) | Coronary Angiography (CAG) | Borderline Coronary Artery LesionsChina
-
Maggie's Pearl, LLCActive, not recruitingPmm2-CDG | Phosphomannomutase 2 Deficiency | Phosphomannomutase 2 Congenital Disorder of Glycosylation | Phosphomannomutase II Congenital Disorder of Glycosylation | Phosphomannomutase II DeficiencyUnited States
-
Washington State UniversityCompletedFocus: To Examine Acute Effects of CBG on Anxiety, Stress, and CognitionUnited States
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East AngliaCompletedSmoking Cessation | Electronic Cigarette Use | Vaping | E-Cig UseUnited Kingdom
-
NYU Langone HealthRecruitingAddiction | Cigarette Smoking | E Cig UseUnited States
-
University of VermontActive, not recruitingNicotine Addiction | Quitting Smoking | E-Cig UseUnited States
-
Hospital Ruber InternacionalRecruitingRefractory Epilepsy | SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationSpain
-
Ionis Pharmaceuticals, Inc.RecruitingMethyl CpG Binding Protein 2 (MECP2) Duplication SyndromeUnited States
-
Ohio State UniversityAmerican Heart Association; Optum, Inc.RecruitingNicotine Dependence | E-Cig UseUnited States
-
Pierre Fabre MedicamentEurotrials Brasil Consultores Cientificos LtdaWithdrawnVenous Disease Classification (CEAP): C2 or C3
-
Alexion PharmaceuticalsCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit DiseaseUnited Kingdom, United States
-
Novartis PharmaceuticalsRecruitingC3 GlomerulopathySpain, France, Germany, Switzerland, United States, Japan, Turkey, China, United Kingdom, Italy, Argentina, Brazil, Greece, Israel, Netherlands
-
Xinjiang Biochemical Pharmaceutical Co., Ltd.CompletedChronic Atrophic Gastritis (CAG)China
-
Duke UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)CompletedSmoking | Nicotine Dependence | Smoking, Cigarette | E-Cig UseUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingCigarette Smoking | Sex Differences | Nicotine Addiction | E-Cig Use
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Smoker | Former Smoker | Tobacco Use Disorder | Never Smoker | E-cig UserUnited States
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly